NOVARTIS AG (NVSEF)
Clinical trial NCT01595984 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2018-08-01 → 2024-03-05 3. primary completion date: 2018-08-01 → 2024-03-05 4. enrollment: 90 → 88 participants
Clinical trial NCT01595984 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2018-08-01 → 2024-03-05 3. primary completion date: 2018-08-01 → 2024-03-05 4. enrollment: 90 → 88 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical